Teva in Czech Republic - Teva Pharmaceutical Industries Ltd.

‘‘
1,600 employees in
the pharmaceutical
sector
➊
Export to many
locations in
the USA and
Western Europe
- Generic medicinal
preparations
- Over-the-counter
drugs
- Active Pharmaceutical
Ingredients
- Herbal extracts
In the last 5 years
Teva has invested
in excess of
125 m USD in
manufacturing
plants in the
Czech Republic
Products comply
with recognized
quality standards
➋
2 locations
➊ Teva Pharmaceuticals CR s.r.o.
Sales & Marketing
Sokolovska 651/136A, Prague
180 00 Czech Republic
Phone: +420 251 007 101
Fax: +420 251 007 110
www.teva.cz
➋ Teva Czech Industries s.r.o.
Pharmaceutical & API
manufacturing plant
Ostravska 29, Opava
747 70 Czech Republic
Phone: +420 553 641 111
Fax: +420 553 642 150
4.5 billion tablets
produced in 2012 in
the Czech Republic
Established
in 1883 in the
Czech Republic
Supports various
charities and patient
organizations
Generic medicines, costs -at entry levelon average 32% less than their
branded equivalents.
59% of all medicines consumed in the
Czech Republic are generic medicines,
which is a potential saving for the
Czech healthcare system.
www.tevapharm.cz
Teva Europe
Piet Heinkade 107
1019 GM Amsterdam
The Netherlands
Tel: +31 (0)20 2193 200
www.tevaeurope.com
HQ/CPE/13/0005
’’
Teva, your partner in healthcare
‘‘
. . . to become the most
indispensable medicines
company for the world,
making a lasting difference
to our patients, customers,
shareholders and employees
’’
Teva in
Czech Republic
In Czech Republic, Teva’s presence can be dated back to 1883. Since the
1940s, the company formerly named ‘Galena’ has been building a strong
reputation, primarily as a producer of active pharmaceutical ingredients and
liquid dosage forms.
Who we are
Teva is a global generic pharmaceuticals leader and one of the top fifteen pharmaceutical companies
in the world. We specialize in the development, manufacturing and marketing of a wide range of
generic and branded products, as well as Active Pharmaceutical Ingredients (APIs).
Teva focuses on diseases and conditions which have the greatest need for new medications:
bio-similars, women’s health, autoimmune diseases, respiratory, central nervous system
and transplantation.
At the heart of everything we do, is our vision to be the most indispensable medicines company for
the world, executing on our obligation to our patients, customers, shareholders and employees.
In 2008, Teva began developing the production of solid dosage forms in the
city of Opava. In the same year, construction of a new state-of-the-art complex
for the production of tablets and capsules was initiated, with an annual
production capacity of 8 billion tablets. This represented an investment of
some CZK 1.5 Billion (USD 75 Million) and was recognized as ’Investment
of the Year’ in the Czech Republic. The facility brought 350 new jobs to the
region and the company is now the region’s largest employer. The Opava
facility includes an Research & Development Unit which employs 60 people
In 2011, construction began on additional pharmaceutical capacity for the
production of tablets – an investment of CZK 1 Billion (USD 50 Million).
In Czech Republic Teva has 2 sites: Teva Pharmaceuticals CR S&M Unit based
in Prague and a Pharmaceutical & API manufacturing plant based in Opava.
FOT0693
FOT0713
Teva’s economic
footprint
‘‘
Teva is a well-respected company and one of the largest
pharmaceutical companies in the Czech Republic, as
well as a prominent member of the Czech Association of
Pharmaceutical Companies. Nationally, Teva ranks second
in generic medicine (units/volume) and sixth overall in
general pharmaceuticals.
All products
comply with
recognized
EU quality
standards
Teva has 2 sites with around 1,600 dedicated employees.
Teva invested CZK 1.5 Billion (USD 75 Million) in 2008 and
CZK1 Billion (USD 50 Million) in the manufacturing plants.
Teva also aims to deliver huge potential savings for
national healthcare systems. Generic medicines, which
on average cost 32% less than their branded equivalents,
account for no more than 59% of all medicines consumed
in the Czech Republic. Adopting generic alternatives means
great potential for more effective use of healthcare budgets
and brings more medicines within patients’ reach.
’’
All products comply with recognized quality standards and
are exported to many countries of the world including the
USA and Western Europe.
Our activities in Czech Republic
In Czech Republic, we take care of production,
packaging and distribution of final dosage forms
of pharmaceuticals, including oral solid dosage
form including cytostatics and high potent tablets
and liquid non-sterile dosage form (solutions,
suspensions, emulsions, syrups, drops, nasal
sprays and soft gelatin capsules). In addition, we
develop, produce and sell active and highly active
pharmaceutical ingredients.
We also offer an integrated portfolio of ergot
alkaloids and a wide portfolio of all therapeutically
used derivatives: morphine alkaloids,
immunosuppressants for treatment of rheumatoid
arthritis, psoriasis, uveitis and autoimmune diseases,
as well as anti-cancer drugs (traditional cytostatics
and modern inhibitors).
Getting our medicines to the patients who need them
We have a wide product portfolio which contains generic
medicinal preparations – such as antiasthmatics,
cytostatics, immunosuppressives, hypolipidemics and
antihypertensives in tablet, capsule and liquid dosage
forms, as well as over-the-counter drugs (OTC), active
pharmaceutical ingredients (API) and herbal extracts.
All products comply with recognised quality standards and
are exported to many countries of the world including the
USA and Western Europe.
‘‘
We focus our involvement in
the community in the
countries in which
we operate
’’
Patients at the heart of
everything we do
At Teva, we’re passionate about improving quality of life and healthcare globally. This is our ongoing
mission as we touch the lives of millions of patients every day, and billions of patients every year.
In the Czech Republic, Teva cooperates with the following patient organizations:
Union ROSKA - this organization provides support for people with multiple sclerosis (MS) and helps
them participate in everyday life. Teva provides educational materials and sponsorship of events
such as the regular patient conference in June and World MS Day, as well as the printed magazine
for members, “ROSKA”.
Civic Association of Young Sclerotics - also provides support for people with MS. Teva provides
educational materials and sponsorship of psychotherapeutic groups of newly diagnosed patients.
Teva: a responsible
healthcare partner
Teva is committed to improving global healthcare. We recognize our
responsibility to support the communities we serve. We focus our involvement
in the community in the countries in which we operate, through a range of
activities to enhance access to medicine and contribute to the well-being of
the communities in which we live. We are proud of our many employees who
volunteer in the community and support them in many ways.
Teva actively supports various organizations in the Czech Republic:
• High school & university cooperation program:
Teva has been cooperating with secondary schools and prestigious Czech
universities for several years. The company provides professional support
and equipment for excursions, internships and students’ work experience.
We co-participate in professional school grants, help build audio-visual
classrooms, support regional and national contests and directly cooperate
on professional research. In 2007, the company initiated the formation of a
4-year apprenticeship program, after which time participants graduate with the
qualification of ‘Chemist Operator’ from Masaryk’s High School in Opava.
The students prepare for their professional lives in theoretical and practical
courses in the newly built training centre’s laboratories.
• Since 1997, when the Charity Commission of Teva was established in Czech
Republic, the company has also supported disabled and disadvantaged citizens
from the local area.